At the same time, we also showed a strong separation of tumors with poor and good survival when performing the CRC patient risk prediction in the set of 246 CMS4 patients with the 27 genes upregulated in our proposed gene-signature in the HCT116 p21-/- cells (Figure 5D). Here, CDKN1A is linked to colorectal carcinoma.